In conclusion, GlaxoSmithKline's shares showed significant gains today, reflecting positive market sentiment and strong ...

Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) reported an 18% revenue growth, with all business segments achieving double-digit growth. The company maintained strong volume growth in both ...

GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...

GlaxoSmithKline says it has built up a valuable intellectual property over the last 15 years in the use of “the unique and distinctive colour purple” on its Seretide inhaler.

Global drugs and health drinks company GlaxoSmithKline has been fined in New Zealand for misleading advertising after two science students found its iconic blackcurrant drink Ribena contained no ...

GlaxoSmithKline posted rising sales yesterday – but shares slid because of fears over its vaccines division. In a boost for the pharma giant’s chief executive Emma Walmsley, turnover increased ...

How GlaxoSmithKline missed red flags in China By Ben Hirschler July 19, 20136:40 AM PDTUpdated July 19, 2013 ...

July 14, 2010 -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their controversial drug Avandia, some doctors are abandoning use of this diabetes treatment.

But GlaxoSmithKline's (GSK) chief executive, JP Garnier, believes that the group's strong product pipeline is helping it fight back. "We're able to take those hits and still move forward," he says. IC ...